Clinical Trial Update: KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes evaluating a KRAS-targeted vaccine in combination with Balstilimab and Botensilimab for stage IV mismatch repair-profi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)
• KRAS-targeted vaccine

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 1 | Status: RECRUITING